<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">cancersp</journal-id><journal-title-group><journal-title xml:lang="ru">Южно-Российский онкологический журнал/ South Russian Journal of Cancer</journal-title><trans-title-group xml:lang="en"><trans-title>South Russian Journal of Cancer</trans-title></trans-title-group></journal-title-group><issn pub-type="epub">2686-9039</issn><publisher><publisher-name>АНО "Перспективы онкологии"</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.37748/2686-9039-2023-4-3-6</article-id><article-id custom-type="edn" pub-id-type="custom">PLGCLL</article-id><article-id custom-type="elpub" pub-id-type="custom">cancersp-223</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Клинические наблюдения</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CLINICAL CASE REPORTS</subject></subj-group></article-categories><title-group><article-title>Клиническое наблюдение пациентки с первично-множественными злокачественными опухолями, включающими первично-множественную меланому</article-title><trans-title-group xml:lang="en"><trans-title>Clinical observation of patients with primary multiple malignant tumors, including primary multiple melanoma</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1957-7363</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Геворкян</surname><given-names>Ю. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Gevorkyan</surname><given-names>Yu. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p> </p><p>Геворкян Юрий Артушевич – д.м.н., профессор, заведующий отделением абдоминальной онкологии № 2, ФГБУ «НМИЦ онкологии» Минздрава России, г. Ростов-на-Дону, Российская Федерация.</p><p>ORCID: <ext-link xlink:href="https://orcid.org/0000-0003-1957-7363," ext-link-type="uri">https://orcid.org/0000-0003-1957-7363,</ext-link> SPIN: 8643-2348, AuthorID: <ext-link xlink:href="https://elibrary.ru/author_profile.asp?id=711165" ext-link-type="uri">711165</ext-link></p></bio><bio xml:lang="en"><p> </p><p>Yuriy A. Gevorkyan – Dr. Sci. (Med.), professor, head of the department of abdominal oncology No. 2, National Medical Research Centre of Oncology, Rostov-on-Don, Russian Federation</p><p>ORCID: <ext-link xlink:href="https://orcid.org/0000-0003-1957-7363," ext-link-type="uri">https://orcid.org/0000-0003-1957-7363,</ext-link> SPIN: 8643-2348, AuthorID: <ext-link xlink:href="https://elibrary.ru/author_profile.asp?id=711165" ext-link-type="uri">711165</ext-link></p></bio><email xlink:type="simple">gevorkyan.000@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0118-4935</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Солдаткина</surname><given-names>Н. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Soldatkina</surname><given-names>N. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p> </p><p>Солдаткина Наталья Васильевна – д.м.н., ведущий научный сотрудник отделения общей онкологии, ФГБУ «НМИЦ онкологии» Минздрава России, г. Ростов-на-Дону, Российская Федерация.</p><p>ORCID: <ext-link xlink:href="https://orcid.org/0000-0002-0118-4935," ext-link-type="uri">https://orcid.org/0000-0002-0118-4935, </ext-link>SPIN: 8392-6679, AuthorID: <ext-link xlink:href="https://elibrary.ru/author_profile.asp?id=440046" ext-link-type="uri">440046</ext-link></p></bio><bio xml:lang="en"><p> </p><p>Natalya V. Soldatkina – Dr. Sci. (Med.), leading researcher of the department of general oncology, National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation.</p><p>ORCID: <ext-link xlink:href="https://orcid.org/0000-0002-0118-4935," ext-link-type="uri">https://orcid.org/0000-0002-0118-4935, </ext-link>SPIN: 8392-6679, AuthorID: <ext-link xlink:href="https://elibrary.ru/author_profile.asp?id=440046" ext-link-type="uri">440046</ext-link></p></bio><email xlink:type="simple">snv-rnioi@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9543-4551</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Бондаренко</surname><given-names>О. К.</given-names></name><name name-style="western" xml:lang="en"><surname>Bondarenko</surname><given-names>O. K.</given-names></name></name-alternatives><bio xml:lang="ru"><p> </p><p>Бондаренко Ольга Константиновна – аспирант, ФГБУ «НМИЦ онкологии» Минздрава России, г. Ростов-на-Дону, Российская Федерация.</p><p>ORCID: <ext-link xlink:href="https://orcid.org/0000-0002-9543-4551" ext-link-type="uri">https://orcid.org/0000-0002-9543-4551</ext-link></p></bio><bio xml:lang="en"><p> </p><p>Olga K. Bondarenko – PhD student, National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation.</p><p>ORCID: <ext-link xlink:href="https://orcid.org/0000-0002-9543-4551" ext-link-type="uri">https://orcid.org/0000-0002-9543-4551</ext-link> </p></bio><email xlink:type="simple">bondarenkoo.olga@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2879-467X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мироненко</surname><given-names>И. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Mironenko</surname><given-names>I. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p> </p><p>Мироненко Ирина Николаевна – ординатор, ФГБУ «НМИЦ онкологии» Минздрава России, г. Ростов-на-Дону, Российская Федерация.</p><p>ORCID: https://orcid.org/0000-0002-2879-467Х </p></bio><bio xml:lang="en"><p> </p><p>Irina N. Mironenko – resident doctor, National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation.</p><p>ORCID: <ext-link xlink:href="https://orcid.org/0000-0002-2879-467X" ext-link-type="uri">https://orcid.org/0000-0002-2879-467X</ext-link></p></bio><email xlink:type="simple">irina.mironenko2016@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5205-6992</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Колесников</surname><given-names>В. Е.</given-names></name><name name-style="western" xml:lang="en"><surname>Kolesnikov</surname><given-names>V. E.</given-names></name></name-alternatives><bio xml:lang="ru"><p> </p><p>Колесников Владимир Евгеньевич – д.м.н., врач-хирург отделения абдоминальной онкологии № 2, ФГБУ «НМИЦ онкологии» Минздрава России, г. Ростов-на-Дону, Российская Федерация.</p><p>ORCID: <ext-link xlink:href="https://orcid.org/0000-0002-5205-6992," ext-link-type="uri">https://orcid.org/0000-0002-5205-6992,</ext-link> SPIN: 9915-0578, AuthorID: <ext-link xlink:href="https://elibrary.ru/author_profile.asp?id=705852" ext-link-type="uri">705852</ext-link></p></bio><bio xml:lang="en"><p> </p><p>Vladimir E. Kolesnikov – Dr. Sci. (Med.), MD, surgeon at the department of abdominal oncology No. 2, National Medical Research Centre of Oncology, Rostov-on-Don, Russian Federation.</p><p>ORCID: <ext-link xlink:href="https://orcid.org/0000-0002-5205-6992," ext-link-type="uri">https://orcid.org/0000-0002-5205-6992,</ext-link> SPIN: 9915-0578, AuthorID: <ext-link xlink:href="https://elibrary.ru/author_profile.asp?id=705852" ext-link-type="uri">705852</ext-link></p></bio><email xlink:type="simple">kolaksay@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3867-4532</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Дашков</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Dashkov</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p> </p><p>Дашков Андрей Владимирович – к.м.н., старший научный сотрудник отделения абдоминальной онкологии № 2, ФГБУ «НМИЦ онкологии» Минздрава России, г. Ростов-на-Дону, Российская Федерация.</p><p>ORCID: <ext-link xlink:href="https://orcid.org/0000-0002-3867-4532," ext-link-type="uri">https://orcid.org/0000-0002-3867-4532,</ext-link> SPIN: 4364-9459, AuthorID: <ext-link xlink:href="https://elibrary.ru/author_profile.asp?id=308799" ext-link-type="uri">308799</ext-link></p></bio><bio xml:lang="en"><p> </p><p>Andrey V. Dashkov – Cand. Sci. (Med.), senior researcher of the department of abdominal oncology No. 2, National Medical Research Centre of Oncology, Rostov-on-Don, Russian Federation.</p><p>ORCID: <ext-link xlink:href="https://orcid.org/0000-0002-3867-4532," ext-link-type="uri">https://orcid.org/0000-0002-3867-4532,</ext-link> SPIN: 4364-9459, AuthorID: <ext-link xlink:href="https://elibrary.ru/author_profile.asp?id=308799" ext-link-type="uri">308799</ext-link></p></bio><email xlink:type="simple">dashkovandrei1968@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБУ «НМИЦ онкологии» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>National Medical Research Centre for Oncology</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>07</day><month>08</month><year>2023</year></pub-date><volume>4</volume><issue>3</issue><fpage>51</fpage><lpage>55</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Геворкян Ю.А., Солдаткина Н.В., Бондаренко О.К., Мироненко И.Н., Колесников В.Е., Дашков А.В., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Геворкян Ю.А., Солдаткина Н.В., Бондаренко О.К., Мироненко И.Н., Колесников В.Е., Дашков А.В.</copyright-holder><copyright-holder xml:lang="en">Gevorkyan Y.A., Soldatkina N.V., Bondarenko O.K., Mironenko I.N., Kolesnikov V.E., Dashkov A.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.cancersp.com/jour/article/view/223">https://www.cancersp.com/jour/article/view/223</self-uri><abstract><p>В последнее время отмечается увеличение числа пациентов с первично-множественными злокачественными опухолями, которые не только поражают один или несколько органов, но и отличаются между собой по гистологической структуре. При этом среди первичных злокачественных новообразований редкой локализацией является меланома кожи. Данная нозология составляет всего 3–5 % от всех опухолей кожи. Меланома связана с высокой смертностью из-за развития выраженного метастатического потенциала, в связи с чем изучение данного злокачественного образования представляет наибольшую актуальность. За последние 50 лет встречаемость первично-множественной меланомы значительно возросла. При этом количество пациентов, имеющих более 2 очагов, возросло до 18 % от числа первично-множественных меланом в течение последних 50 лет. Это подчеркивает важность наблюдения пациентов с меланомой и регулярных осмотров больных на предмет возникновения новых очагов. В данной статье продемонстрирован клинический случай пациентки с установленным диагнозом первично-множественного заболевания с поражением меланомой кожи и прямой кишки. По поводу меланомы кожи пациентке было выполнено широкое иссечение опухоли с пахово-бедренной лимфодиссекцией справа. В последующем проводилась лучевая терапия и химиотерапия. В последующем при комплексном обследовании больной был установлен диагноз злокачественного новообразования нижне-ампулярного отдела прямой кишки с переходом на анальный канал. Пациентке была выполнена лапароскопически-ассистированная брюшно-промежностная экстирпация прямой кишки. По данным гистологического анализа выявлена узловая меланома. Из анамнеза больной среди сопутствующих заболеваний также были выявлены рак молочной железы, миома матки, гемангиома печени, гамартома легкого. Клиническое течение всех злокачественных опухолей было благоприятным, без развития рецидивов и метастазов. Наибольший интерес в данной ситуации представляет первично-множественная меланома в связи с успешным лечением при наиболее неблагоприятном прогнозе. Описанное клиническое наблюдение свидетельствует о необходимости углубленного изучения случаев первично-множественных злокачественных опухолей и поиска механизмов благоприятного течения при этом злокачественных новообразований.</p></abstract><trans-abstract xml:lang="en"><p>Recently, there has been an increase in the number of patients with primary multiple malignant tumors, which not only affect one or more organs, but also differ in their histological structure. At the same time, melanoma of the skin is a rare localization among primary malignant neoplasms. This nosology accounts for only 3–5 % of all skin tumors. Melanoma is associated with high mortality due to the development of a pronounced metastatic potential, and therefore the study of this malignant formation is of the greatest relevance. Over the past 50 years, the incidence of multiple primary melanoma has increased significantly. At the same time, the number of patients with more than 2 lesions has increased to 18 % of the number of primary multiple melanomas over the past 50 years. This emphasizes the importance of monitoring patients with melanoma and regularly examining patients for new lesions. This article demonstrates a clinical case of a patient with a confirmed diagnosis of a primary multiple disease with melanoma of the skin and rectum. For skin melanoma, the patient underwent a wide excision of the tumor with inguinal-femoral lymph node dissection on the right. Subsequently, radiation therapy and chemotherapy were performed. Further, during a comprehensive examination, the patient was diagnosed with a malignant neoplasm of the lower ampullar rectum with a transition to the anal canal. The patient underwent laparoscopic-assisted abdominoperineal extirpation of the rectum. Histological analysis revealed nodular melanoma. From the anamnesis of the patient, among the comorbidities, breast cancer, uterine myoma, hemangioma of the liver and lung hamartoma were also identified. The clinical course of all malignant tumors was favorable, without the development of relapses and metastases. The greatest interest in this situation is the primary multiple melanoma in connection with successful treatment with the most unfavorable prognosis. The described clinical observation indicates the need for an in-depth study of cases of primary multiple malignant tumors and the search for mechanisms for a favorable course of malignant neoplasms in this case.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>первично-множественные злокачественные опухоли</kwd><kwd>первично-множественная меланома</kwd><kwd>меланома кожи</kwd></kwd-group><kwd-group xml:lang="en"><kwd>primary multiple malignant tumors</kwd><kwd>primary multiple melanoma</kwd><kwd>melanoma of the skin</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Солдаткина Н.В., Кит О.И., Геворкян Ю.А., Милакин А.Г. Первично-множественный колоректальный рак: клинические аспекты. Терапевтический архив. 2016. Т. 88. № 8. С. 53-58 https://doi.org/10.17116/terarkh201688853-58</mixed-citation><mixed-citation xml:lang="en">Soldatkina NV, Kit OI, Gevorkyan YuA, Milakin AG. Multiple primary colorectal cancer: clinical aspects. Therapeutic Archive. 2016;88(8):53–58. (In Russ.). https://doi.org/10.17116/terarkh201688853-58, EDN: WKGCEF</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Кит О.И., Геворкян Ю.А., Солдаткина Н.В., Харагезов Д.А., Колесников В.Е., Милакин А.Г. Первично-множественный колоректальный рак: возможности миниинвазивных оперативных вмешательств. Колопроктология. 2017. № 1 (59). С. 38-42. https://doi.org/10.33878/2073-7556-2017-0-1-38-42</mixed-citation><mixed-citation xml:lang="en">Kit OI, Gevorkyan YuA, Soldatkina NV, Kharagezov DA, Kolesnikov VE, Milakin AG. Multiple primary colorectal cancer: the possibilities of minimally invasive surgical interventions. Koloproktologia. 2017;(1):38–42. (In Russ.). https://doi.org/10.33878/2073-7556-2017-0-1-38-42, EDN: XVGRMP</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Ilcheva M, Nikolova P, Hadzhiyska V, Mladenov K. Impact of FDG PET/CT on detection of synchronous and metachronous malignancies and clinical management in patients with multiple primary cancers. Neoplasma. 2022 Jul;69(4):948-956. https://doi.org/10.4149/neo_2022_220203N135.</mixed-citation><mixed-citation xml:lang="en">Ilcheva M, Nikolova P, Hadzhiyska V, Mladenov K. Impact of FDG PET/CT on detection of synchronous and metachronous malignancies and clinical management in patients with multiple primary cancers. Neoplasma. 2022 Jul;69(4):948–956. https://doi.org/10.4149/neo_2022_220203N135</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Van Geel A.N., den Bakker M.A., Kirkels W. et al. Prognosis of Primary Mucosal Penile Melanoma: A Series of 19 Dutch Patients and 47 Patients from the Literature. Pp. 143-147. July 01, 2007. PMID: 17656225. https://doi.org/10.1016/j.urology.2007.03.039.</mixed-citation><mixed-citation xml:lang="en">Van Geel AN, den Bakker MA, Kirkels W, Horenblas S, Kroon BBR, de Wilt JHW, et al. Prognosis of primary mucosal penile melanoma: a series of 19 Dutch patients and 47 patients from the literature. Urology. 2007 Jul;70(1):143–147. https://doi.org/10.1016/j.urology.2007.03.039</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Helgadottir H, Isaksson K, Fritz I, Ingvar C, Lapins J, Höiom V, Newton-Bishop J, Olsson H. Multiple Primary Melanoma Incidence Trends Over Five Decades: A Nationwide Population-Based Study. J Natl Cancer Inst. 2021 Mar 1;113(3):318-328. https://doi.org/10.1093/jnci/djaa088. PMID: 32577730; PMCID: PMC7936055.</mixed-citation><mixed-citation xml:lang="en">Helgadottir H, Isaksson K, Fritz I, Ingvar C, Lapins J, Höiom V, et al. Multiple Primary Melanoma Incidence Trends Over Five Decades: A Nationwide Population-Based Study. J Natl Cancer Inst. 2021 Mar 1;113(3):318–328. https://doi.org/10.1093/jnci/djaa088</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Menzies S, Barry R, Ormond P. Multiple primary melanoma: a single centre retrospective review. Melanoma Res. 2017 Dec;27(6):638-640. https://doi.org/10.1097/CMR.0000000000000395. PMID: 29076952.</mixed-citation><mixed-citation xml:lang="en">Menzies S, Barry R, Ormond P. Multiple primary melanoma: a single centre retrospective review. Melanoma Res. 2017 Dec;27(6):638–640. https://doi.org/10.1097/CMR.0000000000000395</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Rastrelli M, Tropea S, Rossi CR, Alaibac M. Melanoma: epidemiology, risk factors, pathogenesis, diagnosis and classification. In Vivo. 2014 Nov-Dec;28(6):1005-11. PMID: 25398793.</mixed-citation><mixed-citation xml:lang="en">Rastrelli M, Tropea S, Rossi CR, Alaibac M. Melanoma: epidemiology, risk factors, pathogenesis, diagnosis and classification. In Vivo. 2014;28(6):1005–1011.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Conrad N, Leis P, Orengo I, Medrano EE, Hayes TG, Baer S, Rosen T. Multiple primary melanoma. Dermatol Surg. 1999 Jul;25(7):576-81. https://doi.org/10.1046/j.1524-4725.1999.98050.x. PMID: 10469118.</mixed-citation><mixed-citation xml:lang="en">Conrad N, Leis P, Orengo I, Medrano EE, Hayes TG, Baer S, et al. Multiple primary melanoma. Dermatol Surg. 1999 Jul;25(7):576–581. https://doi.org/10.1046/j.1524-4725.1999.98050.x</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">DE Simone P, Valiante M, Silipo V. Familial melanoma and multiple primary melanoma. G Ital Dermatol Venereol. 2017 Jun;152(3):262-265. https://doi.org/10.23736/S0392-0488.17.05554-7. Epub 2017 Jan 24. PMID: 28121081.</mixed-citation><mixed-citation xml:lang="en">DE Simone P, Valiante M, Silipo V. Familial melanoma and multiple primary melanoma. G Ital Dermatol Venereol. 2017 Jun;152(3):262–265. https://doi.org/10.23736/S0392-0488.17.05554-7</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Efthymia Soura, Philip J Eliades, Kristen Shannon, Alexander J Stratigos, Hensin Tsao. Hereditary melanoma: Update on syndromes and management: Genetics of familial atypical multiple mole melanoma syndrome. PMID: 26892650 PMCID: PMC4761105 https://doi.org/ 10.1016/j.jaad.2015.08.038</mixed-citation><mixed-citation xml:lang="en">Soura E, Eliades PJ, Shannon K, Stratigos AJ, Tsao H. Hereditary melanoma: Update on syndromes and management: Genetics of familial atypical multiple mole melanoma syndrome. J Am Acad Dermatol. 2016 Mar;74(3):395–407. https://doi.org/10.1016/j.jaad.2015.08.038</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
